Details of the Drug | DrugMAP

General Information of Drug (ID: DMUSTAW)

Drug Name

hESC-derived RPE (MA09-hRPE)

Indication

Disease Entry	ICD 11	Status	REF
Dry age-related macular degeneration	9B75	Phase 1/2	[1]
Myopic macular degeneration	9B75.Y	Phase 1/2	[2]
Stargardt disease	9B70	Phase 1	[3]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D04QLL

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT01344993) Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
2	ClinicalTrials.gov (NCT02122159) Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration
3	ClinicalTrials.gov (NCT01625559) Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)